Features of Childhood Acute Myeloid Leukemia in Iran: a Report from Double Center Study
Acute Myeloblastic Leukemia is one of the important malignancies in children. For better managing the prognosis of this disease, there should be enough information about common features of this malignancy. The aim of this study was to evaluate these common features in children with Acute Myeloblastic Leukemia. A total of 104 eligible children less than 15-year-old have been referred from 2007-2011 to two referral centers for childhood malignancies. Basic epidemiological information recorded in checklists for each individual. Analyzes have been done by SPSS version 22. Out of patients, 57 cases were males (54.8%). The male/female ratio was 1.2. The mean age of patients was 6.5 ± 4.3 years. The majority subtypes of patients were M3, M4, non-M3, and M2, respectively. The common molecular abnormalities were t (15;17) and inv (16). Of patients, 19.2% had an early relapse. The mean age of relapse in patients was 6.7 ± 3.9 years. Sixty patients (57.7%) were alive, and 44 cases (42.3%) died during or after therapy. The three years overall survival rate of patients was 42% in this study. According to our data, AML has the same frequency as compared with data from developing countries. But different epidemiological characteristic was a lower rate of three years overall survival in patients. These data may serve the health authorities for more effective environmental and preventive measurements, purposeful allocation of resources for facilitating up-to-date diagnostic and treatment modalities, psychological support programs for respective family members and educational purposes.
Etemadi A, Sadjadi A, Semnani S, et al. Cancer Registry in Iran: a Brief Overview. Arch Iranian Med 2008;11(5):577-80.
Gurney JG, Bondy ML, editors. Epidemiology of Childhood Cancer Principles & Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006: p. 1-10.
Lanzkowsky P. Leukemias. Manual of Pediatric Hematology and Oncology 4th ed Churchill livingstane Nek, London, Madrid. 2011;17:518-66.
Leukemia. Center for Disease Control and Prevention. (Accessed in May 2015, 3, at http://www.cdc.gov/CDCHome>).
Conter VRC, Sala CRA. Acute Lymphoblastic Leukemia Orphanet Encyclopedia Monza, Italy. Clin Pediatr Univ Milano Bicocca 2004:106.
Pérez-Saldivar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, et al. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer 2011;11:355-66.
Acute Myeloid Leukemia (AML). Leukemia Foundation. (Accessed in May 2015, 10, at www.leukaemia.org.au).
Leukemia.Cancer types. (Accessed in May 2015, 10, at http://www.cancer.gov/types/leukemia
Kheifets L, Shimkhada R. Childhood Leukemia, and EMF: Review of the Epidemiologic Evidence. Bioelectromagnetics 2005;7(Suppl):S51-9.
Rauscher GH, Sandler DP, Poole C, et al. Family History of Cancer and Incidence of Acute Leukemia in Adults. Am J Epidemiol 2002;156(6):517-26.
Wen WQ, Shu XO, Sellers T, et al. Family history of cancer and autoimmune disease and risk of leukemia in infancy: a report from the children's cancer group (The Unites States and Canada). Cancer Causes Control 1997;9(2):161-71.
Perrillat F, Clavel J, Jaussent I, et al. Family Cancer history and risk of childhood acute leukemia (France). Cancer Causes Control 2001;12(10):935-41.
Farhud D, Mahmoudi M, Kamali M, Marzban M, Andonian L, Saffari R. Consanguinity in Iran. Iranian Journal of Public Health. 1991;20(1-4):1-16.
Deschler B, Lübbert M. Acute Myeloid Leukemia: Epidemiology and Etiology. Cancer 2006;107(9):2099-107.
Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood 206;107(9):3481-5.
Xie Y, Davies SM, Xiang Y, et al. Trends in Leukemia Incidence and Survival in the United States (1973-1998). Cancer 2003;97(9):2229-35.
Kolahdoozan S, Sadjadi A, Radmard, et al. Five Common Cancers in Iran. Arch Iran Med 2010;13(2):143-6.
Dastgiri SS, Fozounkhah Sh, Shokrgozar S, et al. Incidence of Leukemia in the Northwest of Iran. Health Promot Perspect 2011;1(1):50-3.
Alebouyeh M. Current Status of Pediatric Oncology in Iran. Arch Iranian Med 2003;6(3):160-2.
Mousavi SM, Gouya MM, Ramazani R, et al. Cancer incidence and mortality in Iran. Ann Oncol 2009;20(3):556-63.
Hjalgrim LL, Rostgaard K, Schmiegelow K, et al. Ageand Sex-Specific incidence of childhood leukemia by immunophenotype in the Nordic countries. J Natl Cancer Inst 2003;95(20):1539-44.
Pui CH, Boyett JM, Relling MV, et al. Sex differences in prognosis for children with Acute Lymphoblastic Leukemia. J Clin Oncol 1999;17(3):818-24.
Mejía-Aranguré JM, Fajardo-Gutiérrez A, Flores-Aguilar H, et al. Environmental Factors contributing to the development of childhood leukemia in children with Down's syndrome. Leukemia 2003;17(9):1905-7.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.